NCT03611673

Brief Summary

The purpose of this study is to determine the impact of a twice daily at-home olfactory training program with a twenty scent, essential oil-based smell test in patients with olfactory dysfunction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 2, 2018

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

June 5, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 2, 2018

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 19, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 19, 2021

Completed
Last Updated

July 20, 2023

Status Verified

July 1, 2023

Enrollment Period

2.9 years

First QC Date

June 5, 2018

Last Update Submit

July 19, 2023

Conditions

Keywords

sense of smellsmell testat-home smell testessential oilolfactory loss

Outcome Measures

Primary Outcomes (2)

  • Change in ability to detect odorants - Sniffin' Sticks

    Sniffin Sticks are a battery of 12 scents within a tube. The subject smells each scent and then chooses from 4 multiple choice options which is the scent they smelled. Increased number of correct responses indicates better sense of smell. 12/12 is the maximum score. 0/12 is the minimum score.

    Change from Baseline to Month 6

  • Change in ability to detect odorants - AROMA

    AROMA is a essential oil based test. The subject is asked to respond if they detect a smell. If yes, they proceed to a 4 multiple choice items and select the item the smell. If no, they proceed to the next item. Higher number correct indicates better sense of smell. It consists of 13 odorants and 1 blank. Improved sense of smell would also increase the number of correctly identified odorants out of the 14 (including noting the 1 blank).

    Change from Baseline to Month 6

Secondary Outcomes (2)

  • Questionnaire of Olfactory Disorders-Negative Statements (QOD-NS)

    Change from Baseline to Month 6

  • SF-12 (Short Form Health Survey)

    Change from Baseline to Month 6

Study Arms (2)

Group A: 15 Scents

EXPERIMENTAL

Participants will be asked to inhale 15 different scents two times a day.

Other: Smell Test

Group B: 4 Scents

ACTIVE COMPARATOR

Participants will be asked to inhale 4 different scents two times a day.

Other: Smell Test

Interventions

Oils are used for each of the different scents. Each scent will be put on an aromatherapy inhaling stick.

Group A: 15 ScentsGroup B: 4 Scents

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have clinical olfactory dysfunction

You may not qualify if:

  • Pregnant women
  • Unable to perform routine follow-up
  • Current participation in another clinical trial during this trial
  • Patients with dementia, Alzheimer's disease, Parkinson's disease, or other neurocognitive disorders
  • Diagnosis of other systemic conditions known to impact the sinonasal cavity such as Wegener's granulomatosis, Churg Strauss, and immunodeficiency
  • Patients who are allergic to any of the smells or components of our olfactory testing
  • Chronic rhinosinusitis, malignant tumors and/or oncologic therapies (radiation/chemotherapy)
  • History of surgery on the nose or paranasal sinuses
  • Patients using medications that may impact olfactory function (i.e. corticosteroids)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

Location

MeSH Terms

Conditions

Anosmia

Condition Hierarchy (Ancestors)

Olfaction DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jennifer Villwock, MD

    University of Kansas Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2018

First Posted

August 2, 2018

Study Start

June 2, 2018

Primary Completion

April 19, 2021

Study Completion

April 19, 2021

Last Updated

July 20, 2023

Record last verified: 2023-07

Locations